Search Within

Renier J Brentjens

Formats
  1. Meeting Abstract (149)
  2. Journal Article (125)
  3. Review (5)
  4. Editorial (3)
  5. Book Section (1)
  6. Conference Paper (1)
  7. Guidelines (1)
  8. Research Letter (1)
Groups
  1. Adult Leukemia (286)
  2. Center for Hematologic Malignancies (286)
  3. Department of Medicine (286)
  4. GSK Faculty (286)
  5. Hematologic Malignancies Research (286)
  6. Hematologic Malignancies, Division of (286)

More Groups

People
  1. Michel Sadelain (116)
  2. Isabelle Riviere (111)
  3. Jae Park (105)
  4. Xiuyan Wang (66)
  5. Terence Purdon (60)
  6. Elizabeth Halton (48)

More People

Years
  1. 2025 (2)
  2. 2023 (3)
  3. 2022 (5)
  4. 2021 (17)
  5. 2020 (26)
  6. 2019 (28)

More Years

Publications
  1. Blood (74)
  2. Journal of Clinical Oncology (26)
  3. Molecular Therapy (21)
  4. Cancer Research (10)
  5. Biology of Blood and Marrow Transplantation (8)
  6. Clinical Cancer Research (8)

More Publications

Publishers
  1. American Society of Hematology (79)
  2. Nature Publishing Group (52)
  3. American Association for Cancer Research (29)
  4. American Society of Clinical Oncology (27)
  5. Elsevier Inc. (25)
  6. Cell Press (6)

More Publishers

Results (286)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase I trial of CD19-targeted EGFRt/19-28z/4-1BBL armored chimeric antigen receptor (CAR) modified T cells in patients with relapsed or refractory chronic lymphocytic leukemia
    Meeting Abstract

    Park, J. H.; Riviere, I.; Wang, X.; Senechal, B.; Bernal, Y.; Halton, E.; Diamonte, C.; Wang, Y.; Brentjens, R. J.; Sadelain, M.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Durable long-term survival of adult patients with relapsed B-ALL after CD19 CAR (19-28z) T-cell therapy
    Meeting Abstract

    Park, J. H.; Riviere, I.; Wang, X.; Senechal, B.; Wang, Y.; Mead, E.; Santomasso, B.; Halton, E.; Diamonte, C.; Bernal, Y.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Baseline and early post-treatment clinical and laboratory factors associated with severe neurotoxicity following 19-28z CAR T cells in adult patients with relapsed B-ALL
    Meeting Abstract

    Park, J. H.; Santomasso, B.; Riviere, I.; Senechal, B.; Wang, X.; Purdon, T.; Wang, Y.; Halton, E.; Diamonte, C.; Li, D.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Development and evaluation of a human single chain variable fragment (scFv) derived BCMA targeted CAR T Cell vector leads to a high objective response rate in patients with advanced MM
    Meeting Abstract

    Smith, E. L.; Mailankody, S.; Ghosh, A.; Masakayan, R.; Staehr, M.; Purdon, T. J.; Halton, E.; Diamonte, C.; Anant, P.; Bernal, Y.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Enhancing CAR T cell anti-tumor efficacy through secreted single chain variable fragment (scFv) immune checkpoint blockade
    Meeting Abstract

    Rafiq, S.; Jackson, H. J.; Yeku, O.; Purdon, T. J.; van Leeuwen, D. G.; Curran, K. J.; Ahmed, R. N.; Cullen, G. D.; Yan, S.; Wang, P.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Development of JCARH125: Optimization of a fully human anti-BCMA CAR for use in the treatment of multiple myeloma
    Meeting Abstract

    Harrington, K.; Wu, R.; Hauskins, C.; Amin, R.; Long, T.; Chen, A.; Rahardjo, A.; Thayer, C.; Navvaro, G.; Myers, M.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Risk of hyponatremia and associated clinical characteristics in patients with acute lymphoblastic leukemia after CD19 targeted chimeric antigen receptor (CAR) T-cells
    Meeting Abstract

    Dixon, B. N.; Daley, R. J.; Horvat, T. Z.; Buie, L. W.; Hsu, M.; Latcha, S.; Brentjens, R. J.; Park, J. H.
    Blood (2017)

    Fulltext@MSK | Save
  • High dose cyclophosphamide and pre-treatment disease burden dictate response and survival in a multicenter clinical trial using CD19-specific CAR T cells for relapsed/refractory B-ALL
    Meeting Abstract

    Curran, K. J.; Margossian, S. P.; Kernan, N. A.; Silverman, L. B.; Park, J. H.; Sauter, C. S.; Smith, E. L.; Boulad, F.; Cancio, M. I.; Forlenza, C.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Armored CAR T cells genetically modified to secrete IL-12 show enhanced efficacy and overcome a hostile tumor microenvironment in mouse ovarian peritoneal carcinomatosis
    Meeting Abstract

    Yeku, O.; Purdon, T.; Spriggs, D.; Brentjens, R.
    Cancer Immunology Research (2017)

    Fulltext@MSK | Save
  • Emerging role of CAR T cells in non-Hodgkin's lymphoma
    Journal Article

    Avanzi, M. P.; Brentjens, R. J.
    Journal of the National Comprehensive Cancer Network (2017)

    Fulltext@MSK | Save